Oral Contraceptive Pill and GnRH Antagonist Versus Long Protocol in IVF Patients

IVI Madrid115 enrolled

Overview

Recent controversy has arisen regarding the use of the pill for cycle planning in GnRH antagonist IVF cycles. The investigators performed this study to compare such a protocol with the gold-standard still today, which is the long-agonist protocol with no previous use of the pill.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

115

Conditions

Infertility

Interventions

levonorgestrel and ethynilestradiolDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 38 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 1st or 2nd IVF cycle * BMI \<30 kg/m2 * regular menstrual cycles * basal FSH \<10 IU and E2 \<60 pg/ml Exclusion Criteria: * Polycystic ovaries * endometriosis * previous ovarian surgery * previous low ovarian response

Locations (1)

Instituto Valenciano de Infertilidad

Madrid, Madrid, Spain

Outcomes

Primary Outcomes

implantation rate

Time frame: 2 weeks after the embryo transfer

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.